Sign Up to like & get
recommendations!
0
Published in 2017 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.6b01180
Abstract: The concept of covalent inhibition of c-Jun N-terminal kinase 3 (JNK3) was successfully transferred to our well validated pyridinylimidazole scaffold varying several structural features in order to deduce crucial structure-activity relationships. Joint targeting of the…
read more here.
Keywords:
pyridinylimidazoles covalent;
jun terminal;
tri tetrasubstituted;
tetrasubstituted pyridinylimidazoles ... See more keywords